Proof of Usefulness Report

Xellar Biosystems

Analysis completed on 3/23/2026

-14.38

Proof of Usefulness Score

Lab Mode

While Xellar Biosystems operates in a highly relevant and innovative space (AI-driven drug discovery), this specific submission is characterized by severe red flags. The claims regarding audience reach ('everyone') and traction ('most people have used my product') are entirely unsubstantiated and absurd for a specialized biotech platform. The lack of verifiable metrics, combined with poor response quality and vague inputs, results in a negative final score according to the calibration guidelines for submissions with red flags.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility0.25)

Audience Reach Impact0.20)

Technical Innovation0.15)

Evidence Of Traction0.25)

Market Timing Relevance0.10)

Functional Completeness0.05)

Subtotal-12.5

Usefulness Multiplierx1.15

Final Score-14

Project Details

Project URL

xellarbio.com

Description

The human body is a holistic system, its biology is multi-faceted and intricately interconnected. Traditional drug discovery and development efforts have relied on simplified models and reductionistic tools to discover and test new drugs. Now it's time to make a change. Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.

Algorithm Insights

Market Position

Early stage requiring focused development

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline